FRANKFURT – Novartis, the Swiss drugmaker, raised its 2024 earnings guidance on Tuesday for the third time buoyed by wider […]
Novartis Lifts 2024 Earnings Outlook Again on Strong Cosentyx Demand Read More »
Novartis (NYSE: NVS), the Swiss pharmaceutical giant, will pay Monte Rosa Therapeutics (NASDAQ: GLUE) $150 million upfront payment for a
Novartis to Pay Monte Rosa $150 Million Upfront to Develop New Class of Drugs Read More »
On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third
Sanofi (NASDAQ: SNY) Posts Q3 Profit Beat on Early Start of Vaccine Sales Read More »
The February hack at UnitedHealth’s (NYSE: UNH) tech unit Change affected the personal information of 100 million people, the U.S.
UnitedHealth Tech Unit Hack Affected 100 Million People, US Health Dept Says Read More »
FRANKFURT – The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent (NYSE:
Roche Calls on Regulators to Block Novo Holdings-Catalent Deal Read More »
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds Read More »
Did you know that the worldwide biotechnology industry is expected to increase at a CAGR of 13.96% from 2024 to
Why Small Cap Biotech Stocks Can Offer Huge Growth Potential? Read More »
On Monday, Novo Nordisk (NYSE: NVO) said an oral version of its drug semaglutide, helped significantly reduce the risk of
Novo Nordisk’s Oral Diabetes Drug Reduces Heart-Related Risks by 14% in Study Read More »
On Monday, Catalent (NYSE: CTLT) CEO Alessandro Maselli said he will remain at the helm of the U.S.-based contract drugmaker
Catalent CEO Alessandro Maselli to Remain In Charge Following Novo Holdings Acquisition Read More »
PARIS – Sanofi (NASDAQ: SNY) agreed on terms to sell a controlling stake in its consumer health unit Opella to
Sanofi Agrees to Sale Terms for Consumer Health Unit, Say French Government Sources Read More »
PARIS – On Monday, Sanofi (NASDAQ: SNY), the French drugmaker, said it had entered exclusive talks to sell a 50%
Sanofi (NASDAQ: SNY) in Exclusive Talks with CD&R to Sell Consumer Health Unit Opella Read More »
NEW YORK – On Thursday, U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission to
Consumer Groups Urge FTC to Block Novo Holdings-Catalent Deal Read More »
The U.S. Food and Drug Administration has put on hold a trial of Novavax’s (NASDAQ: NVAX) COVID-influenza and its standalone
Novavax (NASDAQ: NVAX) Stock Tumbles After FDA Pauses COVID-Flu Vaccine Trial Read More »
GlaxoSmithKline (NYSE: GSK), the British drugmaker, sued Moderna (NASDAQ: MRNA) in U.S. federal court in Delaware on Tuesday, accusing it
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
Britain to Study Use of Lilly’s Weight Loss Drug to Get People Back to Work Read More »
UnitedHealth Group (NYSE: UNH) provided a 2025 profit forecast below Wall Street estimates on Tuesday as it expects pressure across
Johnson & Johnson (NYSE: JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology
Johnson & Johnson (NYSE: JNJ) Posts Better-than-Expected Q3 Results, Raises 2024 Outlook Read More »
On Monday, Vanda Pharmaceuticals (NASDAQ: VNDA) rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per
Vanda Pharmaceuticals (NASDAQ: VNDA) Rejects Cycle Pharma’s Second Takeover Offer Read More »
PARIS – The French government needs guarantees from drugmaker Sanofi (NASDAQ: SNY) that production of its popular Doliprane painkiller will
France Seeks Job Guarantees from Sanofi Over Doliprane Painkiller Production Read More »
Catalent (NYSE: CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to
Catalent (NYSE: CTLT) to Sell Oral Drug Development Site in New Jersey to Ardena Read More »
H Lundbeck A/S has agreed to buy Longboard Pharmaceuticals (NASDAQ: LBPH) for $2.6 billion, marking the biggest deal ever by
H Lundbeck A/S to Acquire Longboard Pharmaceuticals for $2.6 Billion Read More »
NEW YORK – CVS Health (NYSE: CVS) is exiting its core infusion services business and plans to either close or
BENGALURU – Novo Nordisk (NYSE: NVO), whose global profile has risen along with demand for its Wegovy weight-loss drug, is
Novo Nordisk (NYSE: NVO) Bets Big on Talent and AI Partnerships in India Read More »
Sanofi (NASDAQ: SNY) is closing in on a deal to sell its consumer health unit for about 15 billion euros
Sanofi (NASDAQ: SNY) Nears $16 Billion Sale of Consumer Health Unit to CD&R, Source Says Read More »
Copyright © 2025 abbonews.com
